#BEGIN_DRUGCARD DB02036

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H10N2O3S

# Chemical_IUPAC_Name:
N-hydroxy-2-[(2R)-3-oxo-3,4-dihydro-2H-1,4-benzothiazin-2-yl]acetamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide

# HET_ID:
GNR

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H10N2O3S/c13-9(12-15)5-8-10(14)11-6-3-1-2-4-7(6)16-8/h1-4,8,15H,5H2,(H,11,14)(H,12,13)/t8-/m1/s1

# InChI_Key:
InChIKey=UKDWCJNGBPZOBU-MRVPVSSYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2036

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
238.263

# Molecular_Weight_Mono:
238.041212886

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1S17

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.53

# Predicted_LogS:
-2.6

# Predicted_Water_Solubility:
6.23e-01 g/l

# Primary_Accession_No:
DB02036

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
448475

# PubChem_Substance_ID:
46508836

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01627

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@]1(CC(=O)NO)SC2=CC=CC=C2NC1=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:44 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE004091

# Drug_Target_1_GenBank_ID_Protein:
9945838

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
def

# Drug_Target_1_Gene_Sequence:
>507 bp
TCACGCCTGCTGTCGATGCTGCTTTTCCAGCTTCTTGCGGATGCGGTCGCGCTTGAGGGT
GGACAGGTAGTCGACGAACAGCTTGCCGTTGAGGTGGTCGCATTCGTGCTGGATGCATAC
CGCCAGCAGGCCTTCGGCGACTTCCTCGAAGGGGTTGCCATCGCGGTCGAGGGCCTTGAT
CCGGACCTTCTGCGGTCGGTCCACGTTCTCGTAGAAGCCGGGTACCGACAGGCAGCCTTC
CTGGTACTGGTCCATATCCTCGGTCAGCGGTTCGAACTCGGGGTTGATGAATACCCTCGG
CTCGGACTTGTCTTCGCTGAGGTCCATGACCACGATGCGCTTGTGCACGTTCACCTGGGT
CGCGGCGAGGCCGATGCCCGGGGCTTCGTACATGGTTTCGAACATGTCGTCGATCAGCTG
GCGCACCGCGTCGTCGACCACCTCCACCGGTTTGGCGATGGTCCGCAGGCGCGGATCGGG
GAATTCGAGAATGTTCAGGATGGCCAT

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2708

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
19365

# Drug_Target_1_Name:
Peptide deformylase

# Drug_Target_1_Number_of_Residues:
168

# Drug_Target_1_PDB_ID:
1IX1

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_1_Protein_Sequence:
>Peptide deformylase
MAILNILEFPDPRLRTIAKPVEVVDDAVRQLIDDMFETMYEAPGIGLAATQVNVHKRIVV
MDLSEDKSEPRVFINPEFEPLTEDMDQYQEGCLSVPGFYENVDRPQKVRIKALDRDGNPF
EEVAEGLLAVCIQHECDHLNGKLFVDYLSTLKRDRIRKKLEKQHRQQA

# Drug_Target_1_Reaction:
formyl-L-methionyl peptide + H2O = formate + methionyl peptide

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions

# Drug_Target_1_SwissProt_ID:
Q9I7A8

# Drug_Target_1_SwissProt_Name:
DEF_PSEAE

# Drug_Target_1_Synonyms:
EC 3.5.1.88
PDF
Polypeptide deformylase

# Drug_Target_1_Theoretical_pI:
4.73

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02036
